A phase II study of doxorubicin plus paclitaxel followed by weekly paclitaxel as neoadjuvant chemotherapy for breast cancer (SBCCSG-07)

Kenichi Inoue,Hiroyuki Takei,Masafumi Kurozumi,Kazushige Futsuhara,T. Kai,T. Kuroda,S. Ueda,H. Miyake,Y. Hakamada,K. Suemasu,Toshio Tabei

A phase II study of doxorubicin plus paclitaxel followed by weekly paclitaxel as neoadjuvant chemotherapy for breast cancer (SBCCSG-07)

2016

Kenichi Inoue
Hiroyuki Takei
Masafumi Kurozumi
Kazushige Futsuhara
T. Kai
T. Kuroda
S. Ueda
H. Miyake
Y. Hakamada
K. Suemasu
Toshio Tabei

11103 Background: The primary aim of this study was to estimate the rate of clinical and pathologic response to preoperative doxorubicin and paclitaxel followed by weekly paclitaxel in stage II /II...

Keywords:

Pathology
Breast cancer
Phases of clinical research
Oncology
Doxorubicin
Paclitaxel
Pathologic Response
Medicine
Internal medicine
Chemotherapy
stage ii
weekly paclitaxel

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations